Research
CVS analysis says GLP-1s need to cost $350 a month or less
CVS said GLP-1s would save employers money only if priced at $350 a month or less.

CVS Health said a new analysis found GLP-1 drugs would save employers money over time if priced at $350 a month or less. The white paper, released Sunday at the HLTH conference in Las Vegas, compared claims for people who used the drugs with claims for members who had similar health profiles but did not use them.
CVS analyzed three years of claims for commercial members in Aetna. People still taking the drugs after three years had a 34% to 42% decrease in hospitalizations, and ER visit rates fell by up to 12% in the first and second years, according to the report. CVS found $9,400 in medical bill savings per person, offset by $13,300 more in prescription spending, leaving $3,900 in additional costs per person taking GLP-1s. CVS said a price of around $350 per month would balance the costs and medical savings.


